Tredje AP-fonden’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $217M | Buy |
235,889
+970
| +0.4% | +$983K | 1.19% | 13 |
|
|
2025
Q4 | $252M | Buy |
234,919
+482
| +0.2% | +$461K | 1.9% | 9 |
|
|
2025
Q3 | $179M | Sell |
234,437
-70,296
| -23% | -$52.3M | 1.44% | 11 |
|
|
2025
Q2 | $238M | Buy |
304,733
+48,160
| +19% | +$37.4M | 1.89% | 10 |
|
|
2025
Q1 | $212M | Buy |
256,573
+16,450
| +7% | +$13.7M | 1.98% | 9 |
|
|
2024
Q4 | $185M | Buy |
240,123
+33,020
| +16% | +$27.3M | 1.66% | 8 |
|
|
2024
Q3 | $183M | Sell |
207,103
-22,190
| -10% | -$19.9M | 1.66% | 9 |
|
|
2024
Q2 | $208M | Buy |
229,293
+10,000
| +5% | +$8M | 2% | 7 |
|
|
2024
Q1 | $171M | Buy |
219,293
+19,500
| +10% | +$13.9M | 1.77% | 7 |
|
|
2023
Q4 | $116M | Buy |
199,793
+7,170
| +4% | +$4.19M | 1.45% | 10 |
|
|
2023
Q3 | $103M | Buy |
192,623
+1,659
| +0.9% | +$855K | 1.53% | 11 |
|
|
2023
Q2 | $89.6M | Buy |
190,964
+52,367
| +38% | +$22M | 1.27% | 11 |
|
|
2023
Q1 | $47.6M | Buy |
138,597
+11,170
| +9% | +$3.77M | 0.74% | 29 |
|
|
2022
Q4 | $46.6M | Buy |
127,427
+38,996
| +44% | +$13.8M | 0.8% | 25 |
|
|
2022
Q3 | $28.6M | Sell |
88,431
-28,534
| -24% | -$9.04M | 0.59% | 38 |
|
|
2022
Q2 | $37.9M | Buy |
116,965
+4,000
| +4% | +$1.2M | 0.95% | 19 |
|
|
2022
Q1 | $32.4M | Buy |
112,965
+16,500
| +17% | +$4.25M | 0.66% | 29 |
|
|
2021
Q4 | $26.6M | Sell |
96,465
-7,051
| -7% | -$1.79M | 0.51% | 43 |
|
|
2021
Q3 | $23.9M | Buy |
+103,516
| New | +$25.5M | 0.5% | 45 |
|
|
2021
Q2 | – | Sell |
-273,516
| Closed | -$51.1M | – | 199 |
|
|
2021
Q1 | $51.1M | Buy |
273,516
+85,000
| +45% | +$16.6M | 1.22% | 19 |
|
|
2020
Q4 | $31.8M | Sell |
188,516
-60,000
| -24% | -$8.96M | 0.82% | 31 |
|
|
2020
Q3 | $36.8M | Sell |
248,516
-130,000
| -34% | -$20.1M | 1.19% | 17 |
|
|
2020
Q2 | $62.1M | Buy |
378,516
+251,894
| +199% | +$38.7M | 2.57% | 8 |
|
|
2020
Q1 | $17.6M | Buy |
126,622
+22,408
| +22% | +$3.08M | 0.91% | 26 |
|
|
2019
Q4 | $13.7M | Sell |
104,214
-34,000
| -25% | -$3.94M | 0.69% | 35 |
|
|
2019
Q3 | $15.5M | Buy |
138,214
+664
| +0.5% | +$73.9K | 0.74% | 31 |
|
|
2019
Q2 | $15.2M | Buy |
137,550
+916
| +0.7% | +$108K | 0.73% | 33 |
|
|
2019
Q1 | $17.7M | Sell |
136,634
-3,192
| -2% | -$388K | 0.92% | 21 |
|
|
2018
Q4 | $16.2M | Sell |
139,826
-54,752
| -28% | -$6.12M | 0.99% | 22 |
|
|
2018
Q3 | $20.9M | Sell |
194,578
-66,658
| -26% | -$6.66M | 1.01% | 20 |
|
|
2018
Q2 | $22.3M | Buy |
261,236
+59,103
| +29% | +$4.85M | 0.77% | 23 |
|
|
2018
Q1 | $15.6M | Buy |
202,133
+11,796
| +6% | +$950K | 0.56% | 41 |
|
|
2017
Q4 | $16.1M | Buy |
190,337
+9,740
| +5% | +$829K | 0.55% | 42 |
|
|
2017
Q3 | $15.4M | Sell |
180,597
-1,737
| -1% | -$142K | 0.55% | 40 |
|
|
2017
Q2 | $15M | Buy |
182,334
+4,760
| +3% | +$388K | 0.56% | 37 |
|
|
2017
Q1 | $14.9M | Sell |
177,574
-5,521
| -3% | -$442K | 0.59% | 35 |
|
|
2016
Q4 | $13.5M | Buy |
183,095
+5,316
| +3% | +$396K | 0.57% | 42 |
|
|
2016
Q3 | $14.3M | Sell |
177,779
-15,268
| -8% | -$1.22M | 0.64% | 33 |
|
|
2016
Q2 | $15.2M | Sell |
193,047
-4,749
| -2% | -$358K | 0.68% | 30 |
|
|
2016
Q1 | $15.2M | Buy |
197,796
+30,972
| +19% | +$2.34M | 0.69% | 34 |
|
|
2015
Q4 | $14.1M | Buy |
166,824
+103,537
| +164% | +$8.59M | 0.9% | 25 |
|
|
2015
Q3 | $5.3M | Sell |
63,287
-6,933
| -10% | -$585K | 0.52% | 47 |
|
|
2015
Q2 | $5.86M | Buy |
+70,220
| New | +$5.35M | 0.47% | 54 |
|
Other funds holding LLY
VCM
VPM
Tredje AP-fonden's LLY Position: Q1 2026 in Review
Tredje AP-fonden increased its Eli Lilly (LLY) stake by 0.41% in Q1 2026, buying an estimated $983K and bringing the position to 235,889 shares worth $217M. The position accounts for 1.19% of the portfolio, ranked #13.
Tredje AP-fonden first reported a position in LLY in Q2 2015 and has held it in 43 quarters since. The position peaked at $252M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tredje AP-fonden held 235,889 shares of Eli Lilly worth $217M as of Q1 2026.
- Tredje AP-fonden bought 970 Eli Lilly shares in Q1 2026, an estimated $983K.
- Eli Lilly made up 1.19% of Tredje AP-fonden's portfolio in Q1 2026, its #13 holding.
- Tredje AP-fonden first reported a position in Eli Lilly in Q2 2015 and has held it in 43 quarters since.
- Tredje AP-fonden's Eli Lilly position peaked at $252M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tredje AP-fonden's 13F filing for Q1 2026, filed 12 May 2026.